Immunome Insider Sold Shares Worth $2,412,522, According to a Recent SEC Filing
Isaac Barchas, Director, on July 06, 2026, sold 100,000 shares in Immunome (IMNM) for $2,412,522. Following the Form 4 filing with the SEC, Barchas has control over a total of 211,763 common shares of the company, with 103,259 shares held directly and 108,504 controlled indirectly. SEC Filing:
Isaac Barchas, Director, on July 06, 2026, sold 100,000 shares in Immunome (IMNM) for $2,412,522.
Following the Form 4 filing with the SEC, Barchas has control over a total of 211,763 common shares of the company, with 103,259 shares held directly and 108,504 controlled indirectly.
SEC Filing: